Advances in biliary tract cancer research from 2017 annual meeting of the American Society of Clinical Oncology
Zhimin Geng(Children's Hospital of Zhejiang University), Yudong Qiu, Peng Gong, Yinghe Qiu, Tianqiang Song(Tianjin Medical University Cancer Institute and Hospital), Dong Zhang(Capital Medical University), Jingdong Li(Sun Yat-sen University), Shengping Li, Jianying Lou(Second Affiliated Hospital of Zhejiang University), Yu He, Wenlong Zhai(Zhengzhou University)
Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi
July 20, 2017
Cited by 0
Related Papers
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial
|The Lancet. Gastroenterology & hepatology|2021|268
Defects in Ankyrin-Based Membrane Protein Targeting Pathways Underlie Atrial Fibrillation
|Circulation|2011|111
NSUN2-Mediated mRNA m <b>5</b> C Modification Regulates the Progression of Hepatocellular Carcinoma
|Genomics Proteomics & Bioinformatics|2022|72